Acute toxicity study of Dermabin

The problem of improving the therapy of patients with psoriasis and psoriatic arthritis still remains to be one of the most pressing in the up-to-date dermatology, despite a considerable number of the available and newly appeared medications. The aim of research. The purpose of our study was to...

Full description

Bibliographic Details
Main Authors: V. L. Karbovskyy, I. A. Shevchuk, O. V. Kurkina, T. Ye. Makovska
Format: Article
Language:English
Published: Zaporozhye State Medical University 2017-04-01
Series:Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
Subjects:
Online Access:http://pharmed.zsmu.edu.ua/article/view/93456/90551
_version_ 1818487629330513920
author V. L. Karbovskyy
I. A. Shevchuk
O. V. Kurkina
T. Ye. Makovska
author_facet V. L. Karbovskyy
I. A. Shevchuk
O. V. Kurkina
T. Ye. Makovska
author_sort V. L. Karbovskyy
collection DOAJ
description The problem of improving the therapy of patients with psoriasis and psoriatic arthritis still remains to be one of the most pressing in the up-to-date dermatology, despite a considerable number of the available and newly appeared medications. The aim of research. The purpose of our study was to explore the safety of Dermabin use in experiments on animals. Materials and methods. The studies of drug Dermabin acute toxicity under the conditions of its single epicutaneous application at a dose of 3300mg/kg (betamethasone – 1.65 mg/kg, salicylic acid – 100 mg/kg) or single intragastric administration at a dose of 20000 mg/kg (betamethasone – 10 mg/kg, salicylic acid – 600 mg/kg) were carried out on 40 sexually mature rats of both sexes and 40 sexually mature mice of both sexes. The effect of drug Dermabin was evaluated by the following indicators: a) lethality (term animal deaths in each groups, daily); b) toxicity (daily), including irritation, edema and hyperemia in the area of application; c) body weight changes (days 0, 4, 7 and 14); d) macroscopic examination of innards and calculation of their mass coefficients (14 days). Results. The study results showed that both during the epicutaneous application and intragastric administration of drug Dermabin, signs of intoxication in rats and mice were not revealed. The application of drug Dermabin has no effect on body weight dynamics, integrative indicators of functional status of the animals and a relative mass of their innards. Conclusions. The study shows that LD50 for Dermabin drug while epicutaneously application and intragastrically administration to rats and mice is beyond the limits of 15000 mg/kg. According to toxicological classification of substances, drug Dermabin belongs to V class of toxicity – practically nontoxic substances.
first_indexed 2024-12-10T16:40:40Z
format Article
id doaj.art-d22776149c944abc9aa6837748e5a8eb
institution Directory Open Access Journal
issn 2306-8094
2409-2932
language English
last_indexed 2024-12-10T16:40:40Z
publishDate 2017-04-01
publisher Zaporozhye State Medical University
record_format Article
series Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
spelling doaj.art-d22776149c944abc9aa6837748e5a8eb2022-12-22T01:41:15ZengZaporozhye State Medical UniversityAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki2306-80942409-29322017-04-01111612010.14739/2409-2932.2017.1.93456Acute toxicity study of DermabinV. L. KarbovskyyI. A. ShevchukO. V. KurkinaT. Ye. MakovskaThe problem of improving the therapy of patients with psoriasis and psoriatic arthritis still remains to be one of the most pressing in the up-to-date dermatology, despite a considerable number of the available and newly appeared medications. The aim of research. The purpose of our study was to explore the safety of Dermabin use in experiments on animals. Materials and methods. The studies of drug Dermabin acute toxicity under the conditions of its single epicutaneous application at a dose of 3300mg/kg (betamethasone – 1.65 mg/kg, salicylic acid – 100 mg/kg) or single intragastric administration at a dose of 20000 mg/kg (betamethasone – 10 mg/kg, salicylic acid – 600 mg/kg) were carried out on 40 sexually mature rats of both sexes and 40 sexually mature mice of both sexes. The effect of drug Dermabin was evaluated by the following indicators: a) lethality (term animal deaths in each groups, daily); b) toxicity (daily), including irritation, edema and hyperemia in the area of application; c) body weight changes (days 0, 4, 7 and 14); d) macroscopic examination of innards and calculation of their mass coefficients (14 days). Results. The study results showed that both during the epicutaneous application and intragastric administration of drug Dermabin, signs of intoxication in rats and mice were not revealed. The application of drug Dermabin has no effect on body weight dynamics, integrative indicators of functional status of the animals and a relative mass of their innards. Conclusions. The study shows that LD50 for Dermabin drug while epicutaneously application and intragastrically administration to rats and mice is beyond the limits of 15000 mg/kg. According to toxicological classification of substances, drug Dermabin belongs to V class of toxicity – practically nontoxic substances.http://pharmed.zsmu.edu.ua/article/view/93456/90551psoriasisdermatosisDermabinacute toxicity
spellingShingle V. L. Karbovskyy
I. A. Shevchuk
O. V. Kurkina
T. Ye. Makovska
Acute toxicity study of Dermabin
Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
psoriasis
dermatosis
Dermabin
acute toxicity
title Acute toxicity study of Dermabin
title_full Acute toxicity study of Dermabin
title_fullStr Acute toxicity study of Dermabin
title_full_unstemmed Acute toxicity study of Dermabin
title_short Acute toxicity study of Dermabin
title_sort acute toxicity study of dermabin
topic psoriasis
dermatosis
Dermabin
acute toxicity
url http://pharmed.zsmu.edu.ua/article/view/93456/90551
work_keys_str_mv AT vlkarbovskyy acutetoxicitystudyofdermabin
AT iashevchuk acutetoxicitystudyofdermabin
AT ovkurkina acutetoxicitystudyofdermabin
AT tyemakovska acutetoxicitystudyofdermabin